- 询价
- Toxin Technology
- 美国
- rAT101red
- 2025年12月24日
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20
- 保质期：
1-4年
- 英文名：
rSEA
- 库存：
100
- 供应商：
北京孚博
- 规格：
inquire
畅销Toxin technology部分肠毒素产品常备现货，欢迎咨询订购~
Toxin Technology成立于1984年，致力于为工业和科学界提供优质的葡萄球*菌毒素和抗毒素产品。此外，公司还提供测试食品和培养上清液中葡萄球*菌毒素相关服务。
官网链接：https://，www.toxintechnology.com/
Toxin的 #TT606-1mg，TSST-1，1mg
畅销产品列表：
| 中文名称 | Name | Catalog # | Sizes |
| 高纯金黄色葡萄球*菌肠毒素A | SEA | AT101 | 100 µg |
| 高纯金黄色葡萄球*菌肠毒素B | SEB | BT202 | 1 mg |
| 高纯金黄色葡萄球*菌肠毒素C1 | SEC1 | CT111 | 5 mg |
| 高纯金黄色葡萄球*菌肠毒素C2 | SEC2 | CT222 | 10 mg |
| 高纯金黄色葡萄球*菌肠毒素C3 | SEC3 | CT333 | inquire |
| 高纯金黄色葡萄球*菌肠毒素D | SED | DT303 | inquire |
| 高纯金黄色葡萄球*菌肠毒素E | SEE | ET404 | 100 µg |
| 高纯金黄色葡萄球*菌肠毒素H | SEH | SEH-1 | 1 mg |
| 高纯金黄色葡萄球*菌肠毒素J | SEJ | SEJ-1 | 5 mg |
| 高纯金黄色葡萄球*菌肠毒素K | SEK | SEK-1 | 10 mg |
| 高纯金黄色葡萄球*菌外毒素TSST-1 | TSST-1 | TT606 | inquire |
| 高纯ExfoliativeToxin A | ExfoliativeToxin A | ST101 | inquire |
| 重组SEA | rSEA | rAT101 | inquire |
| 重组SEB | rSEB | rBT202 | inquire |
| 重组SEC-3 | rSEC-3 | rCT333 | inquire |
| 重组SED | rSED | rDT303 | inquire |
| 重组SEE | rSEE | rET404 | inquire |
| 重组TSST-1 | rTSST-1 | rTT606 | inquire |
| 高纯减毒SEA | SEA | AT101red | inquire |
| 高纯减毒SEB | SEB | BT202red | inquire |
| 高纯减毒SEC1 | SEC1 | CT111red | inquire |
| 高纯减毒SEC2 | SEC2 | CT222red | inquire |
| 高纯减毒SEC3 | SEC3 | CT333red | inquire |
| 高纯减毒SED | SED | DT303red | inquire |
| 高纯减毒SEE | SEE | ET404red | inquire |
| 高纯减毒SEH | SEH | SEH-1red | inquire |
| 高纯减毒SEJ | SEJ | SEJ-1red | inquire |
| 高纯减毒SEK | SEK | SEK-1red | inquire |
| 高纯减毒TSST-1 | TSST-1 | TT606red | inquire |
| 高纯减毒Exfoliative Toxin A | Exfoliative Toxin A | ST101red | inquire |
| 重组减毒SEA | rSEA | rAT101red | inquire |
| 重组减毒SEB | rSEB | rBT202red | inquire |
| 重组减毒SEC-3 | rSEC-3 | rCT333red | inquire |
| 重组减毒SED | rSED | rDT303red | inquire |
| 重组减毒SEE | rSEE | rET404red | inquire |
| 重组减毒TSST-1 | rTSST-1 | rTT606red | inquire |
| 葡萄球*菌肠毒素类毒素 | SEA-X | AT101-X | inquire |
| 葡萄球*菌肠毒素类毒素 | SEB-X | BT202-X | inquire |
| SEB HRPO 偶联亲和纯化绵羊抗体 | Anti - SEB | SLBC202 | inquire |
| SEC HRPO 偶联亲和纯化绵羊抗体 | Anti - SEC | SLCC111 | inquire |
| SED HRPO 偶联亲和纯化绵羊抗体 | Anti - SED | SLDC303 | inquire |
| SEE HRPO 偶联亲和纯化绵羊抗体 | Anti - SEE | SLEC404 | inquire |
| TSST-1 HRPO 偶联亲和纯化绵羊抗体 | Anti - TSST-1 | SLTC101 | inquire |
| ET-A HRPO 偶联亲和纯化绵羊抗体 | Anti - ET-A | SLSC505 | inquire |
| DNase HRPO 偶联亲和纯化绵羊抗体 | Anti - DNase | SLNC101 | inquire |
| 溶血蛋白 HRPO 偶联亲和纯化绵羊抗体 | Anti- α-Hemolysin | SLHC101 | inquire |
| SEA 生物素偶联亲和纯化绵羊抗体 | Anti - SEA | SBAC101 | inquire |
| SEB 生物素偶联亲和纯化绵羊抗体 | Anti - SEB | SBBC202 | inquire |
| SEC 生物素偶联亲和纯化绵羊抗体 | Anti - SEC | SBCC111 | inquire |
| SED 生物素偶联亲和纯化绵羊抗体 | Anti - SED | SBDC303 | inquire |
| SEE 生物素偶联亲和纯化绵羊抗体 | Anti - SEE | SBEC404 | inquire |
| TSST-1 生物素偶联亲和纯化绵羊抗体 | Anti - TSST-1 | SBTC101 | inquire |
| ET-A 生物素偶联亲和纯化绵羊抗体 | Anti - ET-A | SBSC505 | |
| DNase 生物素偶联亲和纯化绵羊抗体 | Anti - DNase | SBNC101 | |
| 溶血蛋白 生物素偶联亲和纯化绵羊抗体 | Anti- α-Hemolysin | SBHC | |
| Anti-SEA, γ2b, Xreacts with SEE. Overlaps Zn++ MHC binding site, requires Zn++ for binding. (Kappler & Marrack) | Anti-SEA, γ2b, Xreacts with SEE. Overlaps Zn++ MHC binding site, requires Zn++ for binding. (Kappler & Marrack) | MA108 | 1mg |
| Prepared against Staphylococcal Enterotoxin B, IgG; Reactivity: Anti-SEB & SEC. | Prepared against Staphylococcal Enterotoxin B, IgG; Reactivity: Anti-SEB & SEC. | MBI202 | 1mg |
| Anti-SEB, γ1, 6.0 nM, Not overlapping with the SEB MHC or TCR, interaction site (Kappler & Marrack) | Anti-SEB, γ1, 6.0 nM, Not overlapping with the SEB MHC or TCR, interaction site (Kappler & Marrack) | MB344 | 1mg |
| Anti-SEB, γ2b, 95 nM, Not overlapping with the SEB MHC or TCR, interaction site (Kappler & Marrack) | Anti-SEB, γ2b, 95 nM, Not overlapping with the SEB MHC or TCR, interaction site (Kappler & Marrack) | MB327 | 1mg |
| Anti-SEB, γ1, 5.2 nM, Overlaps with the SEB MHC interaction site. , (Kappler & Marrack) | Anti-SEB, γ1, 5.2 nM, Overlaps with the SEB MHC interaction site. , (Kappler & Marrack) | MB2B33 | 1mg |
| Anti-SEB, γ1, 9.3 nM, Overlaps with the SEB TCR interaction site. (Kappler & Marrack) | Anti-SEB, γ1, 9.3 nM, Overlaps with the SEB TCR interaction site. (Kappler & Marrack) | MB87 | 1mg |
| Anti-SEC, γ1, Reacts with SEC1 (1.5nM) > SEC3 (20nM) > SEC2 (75nM) (Kappler & Marrack) | Anti-SEC, γ1, Reacts with SEC1 (1.5nM) > SEC3 (20nM) > SEC2 (75nM) (Kappler & Marrack) | MC165 | 1mg |
| Prepared against Toxic Shock Syndrome Toxin-1, (Formerly Cat. # TS-2) IgG; Reactivity: Anti-TSST-1. | Prepared against Toxic Shock Syndrome Toxin-1, (Formerly Cat. # TS-2) IgG; Reactivity: Anti-TSST-1. | MCTS-1 | 1mg |
| 天然链球菌致热外毒素B | SPE-B | PTB222 | inquire |
| 重组链球菌致热外毒素A | rSPE-A (Allele-1) | rPTA111 | inquire |
| 重组链球菌致热外毒素C | rSPE-C | rPTC333 | inquire |
| 绵羊抗SPE-A抗体 | Anti-SPE-A | PSA111 | inquire |
| 兔抗SPE-A抗体 | Anti-SPE-A | RPSA1 | inquire |
| 兔抗SPE-B抗体 | Anti-SPE-B | PSB222 | inquire |
| 兔抗SPE-C抗体 | Anti-SPE-C | PSC333 | inquire |
| 亲和纯化兔抗SPE-A抗体 | Anti - SPE-A | PAI111 | inquire |
| 亲和纯化HRPO偶联 SPE-A抗体 | Anti - SPE-A | PAC111 | inquire |
| 亲和纯化兔抗SPE-B抗体 | Anti - SPE-B | PBI222 | inquire |
| 亲和纯化HRPO偶联 SPE-B抗体 | Anti - SPE-B | PBC222 | inquire |
| 亲和纯化兔抗SPE-C抗体 | Anti - SPE-C | PCI333 | inquire |
| 亲和纯化HRPO偶联 SPE-C抗体 | Anti - SPE-C | PCC333 | inquire |
| 链球菌肽聚糖 | Streptococcal peptidoglycan | SRPG1 | 10 mg |
| 鼠源志贺毒素抗体 | STX1-9C9 | STX1-9C9 | 1mg |
| 鼠源志贺毒素抗体 | STX1-3C10 | STX1-3C10 | 1mg |
| 鼠源志贺毒素抗体 | STX1-10D11 | STX1-10D11 | 1mg |
| 鼠源志贺毒素抗体 | STX2-BB12 | STX2-BB12 | 1mg |
| 鼠源志贺毒素抗体 | STX1-13C4 | STX1-13C4 | 1mg |
| 鼠源志贺毒素抗体 | STX2-11E10 | STX2-11E10 | 1mg |
| 志贺毒素混合单克隆抗体 | STXPI-1 | STXPI-1 | 1mg |
| HRPO偶联志贺毒素混合单克隆抗体 | STXPC-1 | STXPC-1 | 0.5mL |
| 生物素偶联志贺毒素混合单克隆抗体 | BSTXPC-1 | BSTXPC-1 | 0.5mL |
| 低纯志贺毒素-1 | STX-1 (Formerly, SLT-1) | Partially Purified Shigatoxin-1* | 0.5 mg |
| 低纯志贺毒素-2 | STX-2 (Formerly, SLT-2) | Partially Purified Shigatoxin-2* | 0.5 mg |
| Ricin (RCA 60) Toxoid | RCAX-1 | Ricin (RCA 60) Toxoid | 1 mg |
| Anti-Ricin, Polyclonal Rabbit IgG | LRCAI-1 | Anti-Ricin, Polyclonal Rabbit IgG | 1 mg |
| Anti-Ricin IgG-HRPO | RCAC-1 | Anti-Ricin IgG-HRPO | 0.5 mL |
| Abrin Toxin (Mixed Isomers) | ABR-1 | Abrin Toxin (Mixed Isomers) | 1 mg |
| Abrin Toxoid | ABRX-1 | Abrin Toxoid | 1 mg |
| Anti-Abrin | AABR-1 | Anti-Abrin | Inquire |
| anti - O1a (1) | anti - O1a (1) | LMO1 | Inquire |
| anti - O1a (1,2) | anti - O1a (1,2) | LMO12 | Inquire |
| anti - O3a (4) | anti - O3a (4) | LMO3 | Inquire |
| anti - O4a (7,9) | anti - O4a (7,9) | LMO4A | Inquire |
| anti - O4b (6) | anti - O4b (6) | LMO4B6 | Inquire |
| anti - O4b (5,6) | anti - O4b (5,6) | LMO4B56 | Inquire |
| anti - O4d (8) | anti - O4d (8) | LMO4D | Inquire |
| anti - HA | anti - HA | LMHA | Inquire |
| anti - HC | anti - HC | LMHC | Inquire |
| anti - HD | anti - HD | LMHD | Inquire |
新产品 热源性的SPE相关产品，详见：
| Streptococcal Reagents | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Streptococcal Peptidoglycan | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Description | Catalog # | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Streptococcal peptidoglycan | ST*PG1, ATTC #29213 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
孚博生物常备库存产品
品牌、货号、名称、包装如下：
Toxin technology#BT202，SEB，1mg；
Toxin technology#BT202red，SEB(Staphylococcal Enterotoxins B)，1mg；
Toxin technology#ET404，SEE，100ug；
Toxin technology#DT303，SED，100ug；
Toxin technology#TT606，TSST-1，100ug；
Toxin technology#AT101，SEA，100ug；
Toxin technology#HT101，Alpha Hemolysin highly purified，100ug；
Toxin technology#HP101，Alpha Hemolysin - partially purified，10000Units；
IRA#SE-121-0.72mg，17β-ESTRADIOL，25片；
Research Diets#D12492，60%高脂饲料（research diets），12.5KG
了解更多产品和定制服务信息请留言，或 直接与我们销售人员联系。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验toxin tech
使用DNA重组生物技术，把天然的或人工合成的遗传物质定向插入细菌、酵母菌或哺乳动物细胞中，使之充分表达，经纯化后而制得的疫苗。应用基因工程技术能制出不含感染性物质的亚单位疫苗、稳定的减毒疫苗及能预防多种疾病的多价疫苗。如把编码乙型肝炎表面抗原的基因插入酵母菌基因组，制成DNA重组乙型肝炎疫苗；把乙肝表面抗原、流感病毒血凝素、单纯疱疹病毒基因插入牛痘苗基因组中制成的多价疫苗等。
剂称为“疫苗”，以细菌代谢产物――毒素制备的制剂称为“类毒素”。随着现代技术的发展，实现了更为有效抗原的纯化和提取，基因重组抗原以及人工合成抗原等均可作为防病治病的生物制品，国际上倾向把上述各种名称统称为“疫苗”。 按照疫苗研制的技术，可把疫苗分类为传统疫苗和新型疫苗。前者包括灭活疫苗、减毒活疫苗和从天然生物体某些成分制成的亚单位疫苗。新型疫苗主要指应用现代生物工程技术研制的疫苗，如核酸疫苗、T细胞疫苗、树突状细胞疫苗等。传统与新型疫苗的特点和不同点见表。
酵母 表达 重组HBsAg 地鼠肾 细胞培养 地鼠肾或人二倍体细胞 减毒活病毒株 减毒活病毒株 减毒活病毒株 减毒活病毒株 病毒亚单位 灭活病毒 灭活病毒 口服 皮下接种 皮下接种 皮下接种 皮下接种 皮下接种 皮下接种 活疫苗的不利之处在于：①在接种者体内增殖中有恢复毒力的潜在危险性；②野毒株感染可干扰疫苗株的免疫
技术资料